Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2020-04-24 2020-04-17
Drug Identification Number 02298589 02298589
Brand name AVAMYS AVAMYS
Common or Proper name fluticasone furoate nasal spray fluticasone furoate nasal spray
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients FLUTICASONE FUROATE FLUTICASONE FUROATE
Strength(s) 27.5MCG 27.5MCG
Dosage form(s) SPRAY, METERED DOSE SPRAY, METERED DOSE
Route of administration NASAL NASAL NASAL NASAL
Packaging size 120 120
ATC code R01AD R01AD
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-04-15 2020-04-15
Estimated end date 2020-05-01 2020-05-01
Actual end date 2020-04-23
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments